AAVantgarde Alternatives & Competitors
12 companies similar to AAVantgarde — Pioneering treatments for Stargardt disease and Usher 1B, addressing the root ca...
LifestyleRx
Virtual Care for Type 2 Diabetes Reversal
PhotonPharma
An immuno-oncology company unleashing the body to fight cancer
Fort Collins, United Stat...
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
Chicago, United States
Ocular Therapeutix, Inc.
Bedford, United States
Track all AAVantgarde competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Ocugen
Approaching healthcare innovation with purpose and agility to deliver new breakthroughs fo...
Malvern, United States
Stēto
Creating continuous care in diabetes
Paris, France
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Corstasis Therapeutics
Advancing Options for Patients Suffering from Edema Associated with Congestive Heart Failu...
Henderson, United States
Brenus Pharma
Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Lyon, France
Dunad Therapeutics
Tunable covalent chemistry with a deep understanding of disease biology to develop transfo...
Cambridge, United States
Adverum Biotechnologies
We are on a global mission to establish gene therapy as a new standard of care for the lea...
Redwood City, United Stat...
Stoparkinson Healthcare Systems Inc
Developing a wearable device for alleviation of Parkinson disease symptoms
San Mateo, United States
About AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the disease
Developing Gene Therapies, Clinical Trial Advancement, Scientific Research and Development
Patients with Inherited Retinal Disorders, Healthcare Providers, Ophthalmologists
Gene Therapy, Inherited Retinal Diseases, Stargardt Disease, Usher Syndrome, AAVantgarde Bio, Clinical Stage Biotechnology, Translational Science, Ophthalmology, Rare Diseases, Retinal Disorders
B2D, B2C, B2B
Product Sales, Service Fee, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches AAVantgarde and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at AAVantgarde on 28 Jan 2026. The 12 companies listed here were last checked between 17 Sep 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.